Shareholdings
| Concept |
As at 2025-03-31 |
2024-04-01 to 2025-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues |
6
xbrli:pure
|
— |
| Carrying amount |
43,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
2
xbrli:pure
|
| Total acquisition cost for increased shares | — |
349,000,000
JPY
|
| Reason for increase in number of shares | — |
株式を取得したセルジェンテック株式会社及びAOI Biosciences株式会社が保有する細胞培養分野の知見や技術が、当社ウェルネス事業部門の発展拡大に寄与する為
|
| Number of issues whose number of shares decreased | — |
xbrli:pure
|
| Total sale amount for decreased shares | — |
JPY
|
| Shares other than those not listed | ||
| Number of issues |
17
xbrli:pure
|
— |
| Carrying amount |
2,090,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
1
xbrli:pure
|
| Total acquisition cost for increased shares | — |
8,000,000
JPY
|
| Reason for increase in number of shares | — |
企業間取引の強化
|
| Number of issues whose number of shares decreased | — |
3
xbrli:pure
|
| Total sale amount for decreased shares | — |
14,000,000
JPY
|